Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche!
Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
FDI World Dental Federation Launches Toolkit To Make Dentistry More Sustainable
Brigham and Women's Hospital, Harvard Medical School, USA
BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma
Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib
